NCT03087929View on ClinicalTrials.gov

Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

September 20, 2013

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Lymphoma, Follicular
Interventions
OTHER

Follow up

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03087929 - Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon | Biotech Hunter | Biotech Hunter